HepaCAM inhibits the malignant behavior of castration-resistant prostate cancer cells by downregulating Notch signaling and PF-3084014 (a γ-secretase inhibitor) partly reverses the resistance of refractory prostate cancer to docetaxel and enzalutamide in vitro
Du, Zhongbo, Li, Luo, Sun, Wei, Wang, Xiao, Zhang, Yao, Chen, Zhixiong, Yuan, Mengjuan, Quan, Zhen, Liu, Nanjing, Hao, Yanni, Li, Ting, Wang, Jinhua, Luo, Chunli, Wu, XiaohouLanguage:
english
Journal:
International Journal of Oncology
DOI:
10.3892/ijo.2018.4370
Date:
April, 2018
File:
PDF, 1.87 MB
english, 2018